Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qifeng Yang

Showing results (321-330 of 324) with videos related to

Pageof 33
Sort By:
You have reached the last page of results.This site can display upto 324 results.
Nature Communications|April 24, 2024
High clonal diversity and spatial genetic admixture in early prostate cancer and surrounding normal tissueNing Zhang, Luuk Harbers, Michele Simonetti, et al.
Plos Medicine|June 19, 2009
DEAR1 is a dominant regulator of acinar morphogenesis and an independent predictor of local recurrence-free survival in early-onset breast cancerSteven T Lott, Nanyue Chen, Dawn S Chandler, et al.
Cancer Communications (London, England)|November 5, 2021
Serum semaphorin 4C as a diagnostic biomarker in breast cancer: A multicenter retrospective studyYa Wang, Long Qiao, Jie Yang, et al.
Oncotarget|March 26, 2016
Development and validation of a surgical-pathologic staging and scoring system for cervical cancerShuang Li, Xiong Li, Yuan Zhang, et al.
Pageof 33

Showing results (321-330 of 324) with videos related to

Sort By:
Pageof 33
You have reached the last page of results.This site can display upto 324 results.
Nature Communications|April 24, 2024
High clonal diversity and spatial genetic admixture in early prostate cancer and surrounding normal tissueNing Zhang, Luuk Harbers, Michele Simonetti, et al.
Plos Medicine|June 19, 2009
DEAR1 is a dominant regulator of acinar morphogenesis and an independent predictor of local recurrence-free survival in early-onset breast cancerSteven T Lott, Nanyue Chen, Dawn S Chandler, et al.
Cancer Communications (London, England)|November 5, 2021
Serum semaphorin 4C as a diagnostic biomarker in breast cancer: A multicenter retrospective studyYa Wang, Long Qiao, Jie Yang, et al.
Oncotarget|March 26, 2016
Development and validation of a surgical-pathologic staging and scoring system for cervical cancerShuang Li, Xiong Li, Yuan Zhang, et al.
Pageof 33